Incidence and Predictors of Liver-Related Events in Patients With Nonalcoholic Fatty Liver Disease

Editorial: The tip of the non‐alcoholic fatty liver disease iceberg—the more we know, the smaller it gets?

“…Indeed, progression from one stage of fibrosis progression may take 14.3 years in patients with NAFLD and 7.1 years in patients with NASH 5 . Also, the leading cause of mortality in these patients is cardiac and not hepatic 6–8 . Overall mortality and liver‐related mortality increase with the fibrosis stage in patients with NAFLD 9 .…”

“… 5 Also, the leading cause of mortality in these patients is cardiac and not hepatic. 6 , 7 , 8 Overall mortality and liver‐related mortality increase with the fibrosis stage in patients with NAFLD. 9 Thus, simple identification of a “fatty liver” based on clinical examination and ultrasound is not enough, and patients should be evaluated to stratify them into risk groups “fibrosis” and provided targeted interventions to mitigate the risk.…”